News search
Research 13 Sep 2024 RESILIENCE is a clinical trial funded by the European Commission (H2020 Programme) that aims to reduce the prevalence of heart failure in cancer survivors |
About the CNIC 30 Aug 2024 |
Research 30 Aug 2024 Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine |
About the CNIC 2 Oct 2023 |
Research 21 Jun 2023 A new CNIC study shows that low-grade systemic inflammation triggered by subcinical atherosclerosis accelerates epigenetic aging in otherwise healthy young individuals |
Research 12 Dec 2022 The results of the SPHERE-HF study are published in the European Journal of Heart Failure. SPHERE-HF is a multicenter academic clinical trial led by investigators at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Hospital Clínic de Barcelona |
Research 18 Oct 2022 A study, published in Nature Metabolism, is the first to demonstrate the key role played by mitochondria in adapting metabolism to different energy demands in humans |
Research 26 Aug 2022 The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM |
Research 26 Jul 2022 Adherence to a workplace cardiovascular health-promotion program improves lifestyle and risk factors in healthy individuals |
- 1 of 5
- next ›